Physician profile
Cyrus Abbaschian
NPI 1265662100
$604,967.62
in general payments reported to CMS, 2019-2025
35 companies · $179K in 2025
The $179K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,680 · 2020: $19K · 2021: $44K · 2022: $238K · 2023: $17K · 2024: $105K · 2025: $179K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $248K · Consulting Fee: $45K · Travel and Lodging: $5,173 · Food and Beverage: $3,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $247,838.99 |
| Consulting Fee | $45,100.00 |
| Travel and Lodging | $5,173.06 |
| Food and Beverage | $3,233.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $487,156.22 | 2020-2025 | Attune, Velys |
| Zimmer Biomet Holdings, INC. | $79,112.20 | 2019-2023 | |
| Medical Device Business Services, INC. | $20,131.04 | 2019-2025 | Tfn-Advance, Velys, Attune |
| Uoc USA INC | $4,062.50 | 2025 | Conformity, Ustar, U2 Pf+ |
| Osteoremedies, LLC | $3,441.46 | 2023-2025 | Osteoboost Select 10cc, Remedy Spectrum Gv Spacer, Remedy Spacer |
| Smith+Nephew, INC. | $2,854.66 | 2019-2025 | Stravix, Pico 7, Pico 14 |
| Onkos Surgical, INC. | $1,927.11 | 2024-2025 | Eleos Limb Salvage System |
| Depuy Synthes Sales INC. | $1,750.54 | 2019-2025 | Na, Tfn-Advance, Va-Lcp |
| Stryker Corporation | $1,297.76 | 2019-2025 | Variax, Graftjacket, T2 Alpha |
| Pylant Medical | $994.24 | 2024-2025 | |
| Arthrex, INC. | $531.80 | 2024-2025 | |
| Linkbio Corp | $375.22 | 2025 | |
| Biocomposites INC | $217.33 | 2024-2025 | Stimulan |
| Restor3d, INC. | $164.26 | 2025 | |
| Axogen | $161.44 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Cap |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $125.00 | 2024 | Zynrelef |
| Nuvasive Specialized Orthopedics, INC. | $109.70 | 2019 | |
| Davol INC. | $95.42 | 2022-2023 | Arista Ah Flexitip |
| Innovation Technologies INC | $68.67 | 2023 | Irrisept |
| Bioventus LLC | $46.53 | 2025 | Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $44.12 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Ethicon US, LLC | $38.76 | 2023-2024 | Vistaseal, Stratafix |
| Integra Lifesciences Corporation | $36.80 | 2022 | |
| Avanos Medical | $35.36 | 2021 | |
| Si-Bone, INC. | $33.02 | 2025 | |
| Illuminoss Medical, INC. | $23.06 | 2024 | |
| Cpm Medical Consultants, LLC | $19.19 | 2020 | |
| Ets Wound Care LLC | $17.21 | 2024 | Mirragen Advanced Wound Matrix |
| Polynovo North America LLC | $16.74 | 2022 | |
| Medtronic USA, INC. | $14.75 | 2019 | |
| Acera Surgical, INC. | $13.61 | 2019 | |
| Ossur Americas, INC. | $13.50 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $13.50 | 2024 | Caldolor |
| Pacira Pharmaceuticals Incorporated | $13.32 | 2020 | |
| Medtronic, INC. | $11.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cyrus Abbaschian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.